Logo image of SVA

SINOVAC BIOTECH LTD (SVA) Stock Price, Quote, News and Overview

NASDAQ:SVA - Nasdaq - AGP8696W1045 - Common Stock - Currency: USD

6.47  -0.02 (-0.31%)

SVA Quote, Performance and Key Statistics

SINOVAC BIOTECH LTD

NASDAQ:SVA (2/22/2019, 8:00:00 PM)

6.47

-0.02 (-0.31%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High8.75
52 Week Low5.73
Market Cap368.91M
Shares57.02M
Float40.34M
Yearly Dividend0
Dividend Yield0%
PE14.7
Fwd PEN/A
Earnings (Next)04-21 2022-04-21/amc
IPON/A N/A


SVA short term performance overview.The bars show the price performance of SVA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6 -8 -10

SVA long term performance overview.The bars show the price performance of SVA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of SVA is 6.47 USD. In the past month the price increased by 0.15%. In the past year, price decreased by -21%.

SINOVAC BIOTECH LTD / SVA Daily stock chart

About SVA

Company Profile

Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Company Info

SINOVAC BIOTECH LTD

39 SHANGDI XI ROAD HAIDIAN DISTRICT

BEIJING F4 102200

CEO: Weidong Yin

Phone: 86-10-5693-1800

SINOVAC BIOTECH LTD / SVA FAQ

What is the stock price of SINOVAC BIOTECH LTD today?

The current stock price of SVA is 6.47 USD. The price decreased by -0.31% in the last trading session.


What is the ticker symbol for SINOVAC BIOTECH LTD stock?

The exchange symbol of SINOVAC BIOTECH LTD is SVA and it is listed on the Nasdaq exchange.


On which exchange is SVA stock listed?

SVA stock is listed on the Nasdaq exchange.


What is SINOVAC BIOTECH LTD worth?

SINOVAC BIOTECH LTD (SVA) has a market capitalization of 368.91M USD. This makes SVA a Small Cap stock.


What are the support and resistance levels for SINOVAC BIOTECH LTD (SVA) stock?

SINOVAC BIOTECH LTD (SVA) has a support level at 6.46 and a resistance level at 6.5. Check the full technical report for a detailed analysis of SVA support and resistance levels.


Should I buy SINOVAC BIOTECH LTD (SVA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SINOVAC BIOTECH LTD (SVA) stock pay dividends?

SVA does not pay a dividend.


When does SINOVAC BIOTECH LTD (SVA) report earnings?

SINOVAC BIOTECH LTD (SVA) will report earnings on 2022-04-21, after the market close.


What is the Price/Earnings (PE) ratio of SINOVAC BIOTECH LTD (SVA)?

The PE ratio for SINOVAC BIOTECH LTD (SVA) is 14.7. This is based on the reported non-GAAP earnings per share of 0.44 and the current share price of 6.47 USD. Check the full fundamental report for a full analysis of the valuation metrics for SVA.


What is the Short Interest ratio of SINOVAC BIOTECH LTD (SVA) stock?

The outstanding short interest for SINOVAC BIOTECH LTD (SVA) is 0.2% of its float. Check the ownership tab for more information on the SVA short interest.


SVA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SVA. When comparing the yearly performance of all stocks, SVA is a bad performer in the overall market: 85.87% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SVA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SVA. SVA has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SVA Financial Highlights

Over the last trailing twelve months SVA reported a non-GAAP Earnings per Share(EPS) of 0.44. The EPS increased by 1566.67% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.8%
ROA 8.39%
ROE 13.09%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)1566.67%
Revenue 1Y (TTM)140.71%

SVA Ownership and Analysts


Ownership
Inst Owners26.16%
Ins OwnersN/A
Short Float %0.2%
Short Ratio6.11
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-100%
Revenue Next YearN/A